Moreover, to the best of our knowledge, this study currently includes the largest number of cases and controls to assess the association between FVL mutation and cancer-associated thrombosis, with a total of 364 participants, allowing us to bring conclusions having solid intern validity. This evidence concerns the gene F5 and cancer.